MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-KR-22-0004487
Triphase Pharmaceuticals Private Limited - pharma in Mysore, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2022
₹6.03 Lakh
▲ 233% YoY
Net loss · FY 2022
₹3.36 Cr
Latest filing
EBITDA · FY 2022
-₹2.3 Cr
Latest filing
Authorised capital
₹16.5 Lakh
Registered with MCA
Paid-up capital
₹12.5 Lakh
Issued & subscribed
Company age
20 yrs
Est. 2006
Employees · EPFO
12
Provident fund records
Directors on board
2
As per MCA filings
About Triphase Pharmaceuticals Private Limited
Data last updated:
Triphase Pharmaceuticals Private Limited is a private limited company based in Mysore, Karnataka, India, a subsidiary of Tenshi Kaizen Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 June 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U73100KA2006PTC039605. Its GSTIN is 29AACCT5097P1ZF (Karnataka).
The company has an authorised share capital of ₹16.5 Lakh and a paid-up capital of ₹12.5 Lakh. It is led by directors Perumal Manoharan and Aditya Desiraju.
Its last annual general meeting (AGM) was held on 30 July 2025, and its latest financial statements are for the year ended 31 March 2023. The registered office is at No 694 Double Road Saraswathipuram, Mysore, Karnataka, India – 570009.
As per the financials filed for FY 2022, the company reported a revenue of ₹6.03 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹3.36 Cr and EBITDA of -₹2.3 Cr. Revenue has declined at a compounded annual rate (CAGR) of 107% over three years and 19% over five years.
The company has about 12 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Triphase Pharmaceuticals. Court records list 11 cases involving the company, including 4 filed by the company and 7 filed against it.
Triphase Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-22-0004487). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website triphasepharma.com.
Company details
CIN U73100KA2006PTC039605
Registration Number 039605
Incorporation Date 01 June 2006
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 July 2025
Date of Balance Sheet 31 March 2023
Parent Company Tenshi Kaizen Private Limited
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-KR-22-0004487
Recognitions & Rankings of Triphase Pharmaceuticals
Contact details
Triphase Pharmaceuticals Private Limited's registered office is in Mysore, Karnataka. Its website is triphasepharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressNo 694 Double Road Saraswathipuram, Mysore, Karnataka, India – 570009
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Triphase Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Triphase Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Triphase Pharmaceuticals operates one associated brand: Triphase Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers comprehensive solutions in probiotic products, animal nutrition, and ingredients. | triphasepharma.com |
Business activity
The main business activity of Triphase Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
Financials of Triphase Pharmaceuticals Private Limited
FY 2023 filings availableTriphase Pharmaceuticals Private Limited reported revenue of ₹6.03 Lakh (up 233% YoY) for FY 2022.
Revenue · FY 2022
₹6.03 Lakh ▲ 233%
Net loss · FY 2022
₹3.36 Cr
EBITDA · FY 2022
-₹2.3 Cr
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 233%
3 years · compounded
▲ 107%
5 years · compounded
▼ 19%
Revenue rose 233% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 19%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹6.03 Lakh | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.3 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.36 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Triphase Pharmaceuticals Private Limited, buy the company report.
Board of directors of Triphase Pharmaceuticals Private Limited
Triphase Pharmaceuticals has 2 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Perumal Manoharan Also directs: Mayuresh Business Consultancy Private Limited | Director | 02 Mar 2023 | 3 Years 7 Months | Current |
| Aditya Desiraju Also directs: Synbiopro Nutraceutix (OPC) Private Limited | Director | 02 Mar 2023 | 3 Years 7 Months | Current |
Auditor
Triphase Pharmaceuticals Private Limited is audited by Deloitte Haskins & Sells LLP for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Deloitte Haskins & Sells LLP | FY 2022 | 117366W/W-100018 |
Shareholding
The shareholding of Triphase Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Triphase Pharmaceuticals Private Limited, buy the company report.
Legal cases
Triphase Pharmaceuticals Private Limited has 11 court cases on record: 4 filed by Triphase Pharmaceuticals, 7 filed against it. All cases are disposed.
Total cases
11
Filed by the company
4
Filed against the company
7
Disposed
11
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 8 | 5 | 0 |
| High courts | 2 | 1 | 0 |
| NCLT | 1 | 1 | 0 |
Cases on record (5 of 11)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, BENGALURU, Karnataka | Court case (Com.A.A.) | Filed against the company by Tenshi Kaizen Private Limited | Disposed |
| District court, BENGALURU, Karnataka | Interim or miscellaneous application | Filed by the company against M S Omega Scientific Instruments Private Limited and 1 other | Disposed |
| District court, BENGALURU, Karnataka | Execution petition | Filed against the company by M/S Omega Scientific Instruments Private Limited | Disposed |
| High Court of Karnataka | Interim or miscellaneous application | Filed against the company by M/S Tenshi Kaizen Private Limited | Disposed |
| NCLT, Bengaluru | Company petition | Filed against the company by an individual | Disposed |
To see the full case history of Triphase Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Triphase Pharmaceuticals Private Limited has 8 MSME Form 1 returns on record between 2015 and 2021, listing 17 overdue payments to 8 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 8)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Pci Pest Control Private Limited | |||
| Katalyst Bio Engineering | |||
| Spire Automation and Innovation | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Triphase Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Triphase Pharmaceuticals Private Limited has a workforce of 12 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
Employee count
12
Active EPFO establishments
1
Employee growth
-14.29%
GST
Triphase Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AACCT5097P1ZF | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Triphase Pharmaceuticals Private Limited, buy the company report.
Recent activity
Triphase Pharmaceuticals Private Limited has 12 board changes on record since 2016: 2 appointments and 10 cessations. The latest: Perumal Manoharan ceased to be Additional Director on 29 Sep 2023.
AGM
Triphase Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Jul 2025 as per latest MCA records.
Ceased
Perumal Manoharan ceased to be Additional Director.
Filing
Triphase Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Bangalore.
Ceased
Aditya Arun Kumar ceased to be Director.
Appointed
Aditya Desiraju was appointed as Director.
Ceased
Chandrappa Seetharamaiah ceased to be Director.
Appointed
Perumal Manoharan was appointed as Director.
Ceased
Pudhucode Radhakrishnan Kannan ceased to be Director.
Ceased
Aditya Desiraju ceased to be Director.
Ceased
Irfan Ulla Sharieff ceased to be Director.
Ceased
Suresh Sharma ceased to be Director.
Ceased
Desiraju Rajagopal Rao ceased to be Director.
3 earlier events are in the company report.
Frequently asked questions
Triphase Pharmaceuticals is an active private limited company based in Mysore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 June 2006 (20+ years old) and is registered under CIN U73100KA2006PTC039605.
Triphase Pharmaceuticals has 2 current directors:
- Perumal Manoharan - Director
- Aditya Desiraju - Director
The latest financial statements of Triphase Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 July 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Triphase Pharmaceuticals is 29AACCT5097P1ZF, registered in Karnataka.
The CIN (Corporate Identification Number) of Triphase Pharmaceuticals is U73100KA2006PTC039605. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Triphase Pharmaceuticals has 11 court cases on record: 4 filed by the company and 7 filed against it. Most are in the district courts.
Triphase Pharmaceuticals was incorporated on 01 June 2006, making it 20+ years old. It is registered with the Registrar of Companies, Bangalore.
Perumal Manoharan ceased to be Additional Director on 29 Sep 2023. Aditya Arun Kumar ceased to be Director on 02 Mar 2023. Aditya Desiraju was appointed as Director on 02 Mar 2023. Triphase Pharmaceuticals has 12 board changes on record in total.
Yes, Triphase Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-22-0004487).
Triphase Pharmaceuticals has 8 MSME Form 1 returns on record between 2015 and 2021, listing 17 overdue payments to 8 micro and small suppliers. The latest return was filed on 18 Oct 2021.
Triphase Pharmaceuticals can be reached through the website triphasepharma.com. Its registered office is in Mysore, Karnataka, India.